Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | S63845 |
| Trade Name | |
| Synonyms | MIK655|MIK-655|MIK 655|S-63845|S 63845 |
| Drug Descriptions |
S63845 (MIK655) is a small molecule drug that binds to and inhibits Mcl1, leading to apoptosis in tumor cells (PMID: 27760111, PMID: 32513939). |
| DrugClasses | MCL1 Inhibitor 18 |
| CAS Registry Number | 1799633-27-4 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| A-1155463 + S63845 | A-1155463 S63845 | 0 | 0 |
| A-1331852 + S63845 | A-1331852 S63845 | 0 | 0 |
| ABT-737 + S63845 | ABT-737 S63845 | 0 | 0 |
| Afatinib + ONO-7475 + S63845 | Afatinib ONO-7475 S63845 | 0 | 0 |
| Azacitidine + S63845 | Azacitidine S63845 | 0 | 0 |
| Capmatinib + S63845 | Capmatinib S63845 | 0 | 0 |
| Docetaxel + S63845 | Docetaxel S63845 | 0 | 0 |
| DT2216 + S63845 | DT2216 S63845 | 0 | 0 |
| Erlotinib + ONO-7475 + S63845 | Erlotinib ONO-7475 S63845 | 0 | 0 |
| Erlotinib + S63845 | Erlotinib S63845 | 0 | 0 |
| Gefitinib + ONO-7475 + S63845 | Gefitinib ONO-7475 S63845 | 0 | 0 |
| Lapatinib + S63845 | Lapatinib S63845 | 0 | 0 |
| Lazertinib + ONO-7475 + S63845 | Lazertinib ONO-7475 S63845 | 0 | 0 |
| Navitoclax + S63845 | Navitoclax S63845 | 0 | 0 |
| ONO-7475 + Osimertinib + S63845 | ONO-7475 Osimertinib S63845 | 0 | 0 |
| S63845 | S63845 | 1 | 0 |
| S63845 + Trametinib | S63845 Trametinib | 4 | 0 |
| S63845 + Trastuzumab | S63845 Trastuzumab | 0 | 0 |
| S63845 + Vemurafenib | S63845 Vemurafenib | 1 | 0 |
| S63845 + Venetoclax | S63845 Venetoclax | 0 | 0 |